<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">35244516</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>22</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>02</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1744-5116</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>60</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>Pharmaceutical biology</Title>
          <ISOAbbreviation>Pharm Biol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Yunpi Heluo decoction reduces ectopic deposition of lipids by regulating the SIRT1-FoxO1 autophagy pathway in diabetic rats.</ArticleTitle>
        <Pagination>
          <StartPage>579</StartPage>
          <EndPage>588</EndPage>
          <MedlinePgn>579-588</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/13880209.2022.2042567</ELocationID>
        <Abstract>
          <AbstractText Label="CONTEXT" NlmCategory="BACKGROUND">Yunpi Heluo (YPHL) decoction is a Chinese herbal formula with particular advantages for treating type 2 diabetes. Yet, its exact mechanism of action is not fully understood.</AbstractText>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To examine the therapeutic effect of YPHL on ectopic lipid deposition (EDL) in Zucker diabetic fatty (ZDF) rats and the underlying mechanism.</AbstractText>
          <AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">The ZDF Rats were randomized into five groups, including model, YPHL (200 mg/kg/d for 10 weeks), SIRT1-overexpression (injected with HBAAV2/9-r-SIRT1-3'-flag-GFP), NC (injected with HBAAV2/9-CMV-GFP as blank control) and control group. Pancreatic β-cells obtained from high-lipid-high-glucose fed rats were treated with YPHL (10 mg/mL) for 48 h. Lipid deposition and autophagosomes were analyzed by transmission electron microscopy. Intracellular H<sub>2</sub>O<sub>2</sub> and ROS concentrations were measured by flow cytometry. SIRT1, FOXO1, LC3 and P62 mRNA and protein levels were analyzed using qRT-PCR and Western blots.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Compared with the model group, blood glucose levels in YPHL and si-SIRT1 groups were reduced by 19.3% and 27.9%, respectively. In high-lipid-high-glucose cells treated with YPHL, lipid droplets were reduced and decrease in apoptosis rate (38.6%), H<sub>2</sub>O<sub>2</sub> (31.2%) and ROS (44.5%) levels were observed. After YPHL intervention or SIRT1 overexpression, LC3 and p62 expression increased. Protein expression of SIRT1 and LC3 in model, si-SIRT1, si-NC and si-SIRT1 + YPHL groups was lower than those in control group, while FoxO1 expression was increased. All of these protein level alterations were reversed in the si-NC + YPHL group.</AbstractText>
          <AbstractText Label="DISCUSSION AND CONCLUSIONS" NlmCategory="CONCLUSIONS">YPHL reduced EDL by regulating the SIRT1-FoxO1 autophagy pathway in diabetic rats, which could lead to future perspectives for the treatment of diabetes.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Mao</LastName>
            <ForeName>Zhujun</ForeName>
            <Initials>Z</Initials>
            <Identifier Source="ORCID">0000-0003-1285-6212</Identifier>
            <AffiliationInfo>
              <Affiliation>College of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Shiyu</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>College of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yu</LastName>
            <ForeName>Tao</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>College of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Su</LastName>
            <ForeName>Jinglan</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>College of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chai</LastName>
            <ForeName>Kefu</ForeName>
            <Initials>K</Initials>
            <Identifier Source="ORCID">0000-0002-0918-2790</Identifier>
            <AffiliationInfo>
              <Affiliation>College of Basic Medicine, Zhejiang Chinese Medical University, Ningbo, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Weng</LastName>
            <ForeName>Siying</ForeName>
            <Initials>S</Initials>
            <Identifier Source="ORCID">0000-0002-9110-1098</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Endocrinology, Ningbo Municipal Hospital of TCM, Affliated Hospital of Zhejiang Chinese Medical University, Ningbo, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Pharm Biol</MedlineTA>
        <NlmUniqueID>9812552</NlmUniqueID>
        <ISSNLinking>1388-0209</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D004365">Drugs, Chinese Herbal</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D007004">Hypoglycemic Agents</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D009419">Nerve Tissue Proteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>147604-79-3</RegistryNumber>
          <NameOfSubstance UI="C074639">Foxo1 protein, rat</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 3.5.1.-</RegistryNumber>
          <NameOfSubstance UI="C488368">Sirt1 protein, rat</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 3.5.1.-</RegistryNumber>
          <NameOfSubstance UI="D056564">Sirtuin 1</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001343" MajorTopicYN="N">Autophagy</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003921" MajorTopicYN="N">Diabetes Mellitus, Experimental</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003924" MajorTopicYN="N">Diabetes Mellitus, Type 2</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004365" MajorTopicYN="N">Drugs, Chinese Herbal</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007004" MajorTopicYN="N">Hypoglycemic Agents</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D050356" MajorTopicYN="N">Lipid Metabolism</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009419" MajorTopicYN="N">Nerve Tissue Proteins</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011897" MajorTopicYN="N">Random Allocation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011924" MajorTopicYN="N">Rats, Zucker</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D056564" MajorTopicYN="N">Sirtuin 1</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Insulin resistance</Keyword>
        <Keyword MajorTopicYN="N">pancreas</Keyword>
        <Keyword MajorTopicYN="N">type 2 diabetes</Keyword>
      </KeywordList>
      <CoiStatement>The authors report no conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>4</Day>
          <Hour>12</Hour>
          <Minute>14</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>5</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35244516</ArticleId>
        <ArticleId IdType="pmc">PMC8916783</ArticleId>
        <ArticleId IdType="doi">10.1080/13880209.2022.2042567</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Chai K, Zhang X, Dai M.. 
2013. Influence of Yunpi Heluo granule on proliferation of rat Schwann cells cultured in high glucose and expression of NGF mRNA. Chinese Arch Trad Chinese Med (Chinese). 60:970–973.</Citation>
        </Reference>
        <Reference>
          <Citation>Chan M.
2017. China's burgeoning epidemic of diabetes-associated mortality. JAMA. 317(1):264–266.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28114532</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Etgen GJ, Oldham BA.. 
2000. Profiling of Zucker diabetic fatty rats in their progression to the overt diabetic state. Metabolism. 49(5):684–688.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10831184</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ferraro E, Giammarioli AM, Chiandotto S, Spoletini I, Rosano G.. 
2014. Exercise-induced skeletal muscle remodeling and metabolic adaptation: redox signaling and role of autophagy. Antioxid Redox Signal. 21(1):154–176.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4048572</ArticleId>
            <ArticleId IdType="pubmed">24450966</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Finegood DT, McArthur MD, Kojwang D, Thomas MJ, Topp BG, Leonard T, Buckingham RE.. 
2001. Beta-cell mass dynamics in Zucker diabetic fatty rats. Rosiglitazone prevents the rise in net cell death. Diabetes. 50(5):1021–1029.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11334404</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ghorbani A.
2014. Clinical and experimental studies on polyherbal formulations for diabetes: current status and future prospective. J Integr Med. 12(4):336–345.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25074883</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kern L, Spreckels J, Nist A, Stiewe T, Skevaki C, Greene B, Mernberger M, Elsässer HP.. 
2016. Altered glycogen metabolism causes hepatomegaly following an Atg7 deletion. Cell Tissue Res. 366(3):651–665.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27553638</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim KH, Lee MS.. 
2014. Autophagy-a key player in cellular and body metabolism. Nat Rev Endocrinol. 10(6):322–337.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24663220</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kobyliak N, Falalyeyeva T, Bodnar P, Beregova T.. 
2017. Probiotics supplemented with omega-3 fatty acids are more effective for hepatic steatosis reduction in an animal model of obesity. Probiotics Antimicrob Proteins. 9(2):123–130.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27660157</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Komiya K, Uchida T, Ueno T, Koike M, Abe H, Hirose T, Kawamori R, Uchiyama Y, Kominami E, Fujitani Y, et al. . 
2010. Free fatty acids stimulate autophagy in pancreatic β-cells via JNK pathway. Biochem Biophys Res Commun. 401(4):561–567.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20888798</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Levine B, Yuan J.. 
2005. Autophagy in cell death: an innocent convict?
J Clin Invest. 115(10):2679–2688.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1236698</ArticleId>
            <ArticleId IdType="pubmed">16200202</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li M, Han Z, Bei W, Rong X, Guo J, Hu X.. 
2015. Oleanolic acid attenuates insulin resistance via NF-κB to regulate the IRS1-GLUT4 pathway in HepG2 cells. Evid Based Complement Alternat Med. 2015:643102.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4710921</ArticleId>
            <ArticleId IdType="pubmed">26843885</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li X, Kazgan N.. 
2011. Mammalian sirtuins and energy metabolism. Int J Biol Sci. 7(5):575–587.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3101526</ArticleId>
            <ArticleId IdType="pubmed">21614150</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liang F, Kume S, Koya D.. 
2009. SIRT1 and insulin resistance. Nat Rev Endocrinol. 5(7):367–373.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19455179</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lippai M, Szatmári Z.. 
2017. Autophagy-from molecular mechanisms to clinical relevance. Cell Biol Toxicol. 33(2):145–168.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27957648</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu HY, Han J, Cao SY, Hong T, Zhuo D, Shi J, Liu Z, Cao W.. 
2009. Hepatic autophagy is suppressed in the presence of insulin resistance and hyperinsulinemia: inhibition of FoxO1-dependent expression of key autophagy genes by insulin. J Biol Chem. 284(45):31484–31492.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2781544</ArticleId>
            <ArticleId IdType="pubmed">19758991</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mao ZJ, Weng SY, Lin M, Chai KF.. 
2019. Yunpi Heluo decoction attenuates insulin resistance by regulating liver miR-29a-3p in Zucker diabetic fatty rats. J Ethnopharmacol. 243:111966.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31128151</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Milne JC, Lambert PD, Schenk S, Carney DP, Smith JJ, Gagne DJ, Jin L, Boss O, Perni RB, Vu CB, et al. . 
2007. Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature. 450(7170):712–716.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2753457</ArticleId>
            <ArticleId IdType="pubmed">18046409</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ost A, Svensson K, Ruishalme I, Brännmark C, Franck N, Krook H, Sandström P, Kjolhede P, Strålfors P.. 
2010. Attenuated mTOR signaling and enhanced autophagy in adipocytes from obese patients with type 2 diabetes. Mol Med. 16(7-8):235–246.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2896460</ArticleId>
            <ArticleId IdType="pubmed">20386866</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vainshtein A, Grumati P, Sandri M, Bonaldo P.. 
2014. Skeletal muscle, autophagy, and physical activity: the ménage à trois of metabolic regulation in health and disease. J Mol Med (Berl). 92(2):127–137.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24271008</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang H, Wang D, Wen S.. 
2017. Study on the protective effect and mechanism of Yunpi Heluo prescription on the sciatic nerve of diabetic rats. Zhejiang J Trad Chinese Med (Chinese). 52:176–177.</Citation>
        </Reference>
        <Reference>
          <Citation>Zhang X, Chai K.. 
2010. Application of Yunpi Heluo method in diabetic peripheral neuropathy. Henan Trad Chinese Med (Chinese). 30:734–736.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
